|
[1]
|
Gleen, H.K., Wiley, V., Wilcken, B., et al. (2008) Tow-year pilot study of newbom screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia. Journal of Paediatrics and Child Health, 44, 554-559.
|
|
[2]
|
Grunieiro-Papendieck, L., Chiesa, A., Mendez, V., et al. (2008) Neonatal screening for congenital adrenal hyperplasia: Experience and results in Argentina. Journal of Pediatric Endocrinology & Metabolism, 21, 71-78.
|
|
[3]
|
苗静琨, 万科星, 张娟, 等 (2010) 中华医学会第十五次全国儿科学术大会论文汇编. 重庆地区开展新生儿CAH和G6PD筛查的初步报告, 285-286.
|
|
[4]
|
张瑾, 孙亦骏, 黄美莲, 等 (2004) 南京市新生儿PKU、CH及CAH筛查结果分析. 南京医科大学学报, 24, 92-93.
|
|
[5]
|
Behrman, R.E., et al. (2000) Nelson textbook of pediatrics. 16th Edition, Saunders Company, Philadelphia, 1729-1736.
|
|
[6]
|
Huang, N., Agrawal, V., Giacomini, K.M., et al. (2008) Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and ac-tivities of 15 missense mutation. Proceedings of the National Academy of Sciences of the United States of America, 105, 1733-1738.
|
|
[7]
|
Matteson, K.J., Picado-Leonard, J., Chung, B.C., et al. (1986) Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase) to human chromosome 10. The Journal of Clinical Endocrinology & Metabolism, 63, 789-791.
|
|
[8]
|
Lane, D.E. (2006) Polycysticovary syndrome and its differential diagnosis. Obstetrical & Gynecological Survey, 61, 125-135.
|
|
[9]
|
Cavarzere, P., Camilot, M., Teofoli, F., et al. (2005) Neonatal screening for Congenital adrenal hyperplasia in North- Eastern Italy: A report three years in to the program. Hormone Research, 63, 180-186.
|
|
[10]
|
Nimkarn, S. and New, M.I. (2009) Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Molecular and Cellular Endocrinology, 300, 192-196.
|
|
[11]
|
马定远, 孙云, 陈玉林, 杨冰, 成建, 黄美莲, 等 (2013) 21羟化酶缺陷症基因诊断方法的建立及应用. 中华医学遗传学杂志, 1, 49-53.
|
|
[12]
|
White, P.C. (2009) Neonatal screening for congenital abrenal hyperplasia. Nature Reviews Endocrinology, 5, 490-498.
|
|
[13]
|
Balsamo, A., Baldazzi, L., Menabo, S. and Cicognani, A. (2010) Impact of molecular genetics on congenital abrenal hyperplasia management. Sexual Development, 4, 233-248.
|
|
[14]
|
Nimkarn, S. and New, M.I. (2009) Prenatal diagnosis and treatment of congenital abrenal byperplasia due to 21-hyperplasia deficiency. Molecular and Cellular Endocrinology, 300, 192-196.
|
|
[15]
|
Cardoso, C.B., Fonseca, A.A., De Oliveira, M.F., et al. (2005) Congenital adrenal hyperplasia newborn screening: Riode Janeiro experience. Arquivos Brasileiros de Endocrinologia & Metabologia, 49, 112-119.
|
|
[16]
|
Kim, Y.M., Kang, M.J., Choi, J.-H., et al. (2014) A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17, 20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metabolism Clinical and Experimental, 63, 42-49.
|
|
[17]
|
罗小平, 祝婕 (2006) 先天性肾上腺皮质增生症的诊断和治疗. 实用儿科临床杂志, 8, 5l0-512.
|
|
[18]
|
Lajic, S., Nordenström, A. and Hirvikoski, T. (2011) Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency. Pediatric Adrenal Diseases, 20, 96-105.
|
|
[19]
|
Matthews, D. and Cheetham, T. (2013) What is the best approach to the teenage patient presenting with nonclassical congenital adrenal hyperplasia: Should we always treat with glucocorticoids. Clinical Endocrinology, 78, 338-341.
|
|
[20]
|
Joint LWPSE/ESPE CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology & Metabolism, 87, 4048-4053.
|
|
[21]
|
Nguyen-An, T.T., Brown, J.J. and Warne, G.L. (2006) Growth in congenital hyperplasia. Indian Journal of Pediatrics, 73, 89-94.
|
|
[22]
|
Charmandari, E., Johnston, A., Honour, J.W., et al. (2002) Treatment with flutamide decreases cortisol clearance: Implications for therapy in congenital adrenal hyperplasia. Journal of Pediatric Endocrinology and Metabolism, 15, 435- 439.
|
|
[23]
|
Forest, M.G. (2004) Recent advances in the diagnosis and man-agement of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Reproduction Update, 10, 469-485.
|
|
[24]
|
Meyer-Bahlburg, H.F. (2011) Brain development and cognitive, psychosocial, and psychiatric functioning in classical 21-hydroxylase deficiency. Pediatric Adrenal Diseases, 20, 88-95.
|
|
[25]
|
Charmandari, E., Chrousos, G.P. and Merke, D.P. (2005) Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency. Journal of Pediatric Endocrinology and Metabolism, 18, 97-101.
|
|
[26]
|
Lin-Su, A. and New, M.I. (2007) Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia. Annals of the New York Academy of Sciences, 1117, 345-351.
|
|
[27]
|
Reisch, N., Arlt, W. and Krone, N. (2011) Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research in Paediatrics, 76, 73-85.
|
|
[28]
|
肖慧文, 马华梅 (2011) 先天性肾上腺皮质增生症21羟化酶缺乏患者的生长与最终身高影响因素. 国际儿科学杂志, 3, 210-215.
|
|
[29]
|
Karen, J., Loechner, S.P., et al. (2010) Decreased bone mineral density and vertebral compression fractures in a young adult male with 21-hydroxylase deficiency Congenital adrenal hyperplasia (CAH): Is CAH an unrecognized population at risk for Glucocorticoid-induced osteoporosis. Journal of Pediatric Endocrinology & Metabolism, 23, 179-187.
|